1. Home
  2. ATS vs WVE Comparison

ATS vs WVE Comparison

Compare ATS & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ATS Corporation

ATS

ATS Corporation

HOLD

Current Price

$30.99

Market Cap

3.0B

Sector

N/A

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$12.65

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATS
WVE
Founded
1978
2012
Country
Canada
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.4B
IPO Year
2023
2015

Fundamental Metrics

Financial Performance
Metric
ATS
WVE
Price
$30.99
$12.65
Analyst Decision
Hold
Strong Buy
Analyst Count
1
16
Target Price
$35.00
$30.44
AVG Volume (30 Days)
183.5K
3.2M
Earning Date
02-04-2026
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.14
N/A
Revenue
$2,048,319,324.00
$109,230,000.00
Revenue This Year
$16.92
N/A
Revenue Next Year
$5.13
$16.10
P/E Ratio
$221.51
N/A
Revenue Growth
1.80
103.75
52 Week Low
$20.90
$5.28
52 Week High
$32.73
$21.73

Technical Indicators

Market Signals
Indicator
ATS
WVE
Relative Strength Index (RSI) 61.65 41.05
Support Level $30.21 $12.51
Resistance Level $31.83 $14.15
Average True Range (ATR) 1.20 0.76
MACD 0.16 -0.04
Stochastic Oscillator 85.33 8.29

Price Performance

Historical Comparison
ATS
WVE

About ATS ATS Corporation

ATS Corp is a Canada-based company that provides automation systems. The company designs and builds customized automated manufacturing and testing systems for customers, and provides pre- and post-automation services. The company's products comprise conveyor systems, automated electrified monorails, tray handlers, laser systems, and other hardware and software products. The company also provides pre-automation solutions, including strategic direction and planning services, as well as aftermarket support. The company's clients come from the life sciences, food and beverage transportation, consumer products and electronics, and energy sectors. The company generates the majority of its sales from the North American and European markets.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: